Tien-Li Lee
Gründer bei Aardvark Therapeutics, Inc.
Vermögen: 1 213 $ am 30.04.2024
Profil
Tien-Li Lee has founded Aardvark Therapeutics, Inc. in 2017, where he currently holds the position of Chief Executive Officer & Director.
He was previously the Chief Strategy Officer at NantKwest, Inc. from 2014 to 2017.
Dr. Lee also held several former positions, including Director at SCILEX Pharmaceuticals, Inc. from 2018 to 2023, Independent Director at Scilex, Inc. from 2019 to 2022, and Independent Director at Scilex Holding Co. from 2022 to 2023.
Dr. Lee received an undergraduate degree from the University of California, Berkeley, and a doctorate degree from the University of California San Diego.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SCILEX HOLDING COMPANY
0,00% | 06.03.2023 | 1 409 ( 0,00% ) | 1 213 $ | 30.04.2024 |
Aktive Positionen von Tien-Li Lee
| Unternehmen | Position | Beginn |
|---|---|---|
Aardvark Therapeutics, Inc.
 Aardvark Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel small molecule therapeutics for obesity and metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA. | Gründer | 01.01.2017 |
Ehemalige bekannte Positionen von Tien-Li Lee
| Unternehmen | Position | Ende |
|---|---|---|
SCILEX Pharmaceuticals, Inc.
 SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Direktor/Vorstandsmitglied | 27.08.2023 |
| SCILEX HOLDING COMPANY | Direktor/Vorstandsmitglied | 27.08.2023 |
Scilex, Inc.
 Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | Direktor/Vorstandsmitglied | 01.11.2022 |
| IMMUNITYBIO, INC. | Corporate Officer/Principal | 01.03.2017 |
Ausbildung von Tien-Li Lee
| University of California San Diego | Doctorate Degree |
| University of California, Berkeley | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SCILEX HOLDING COMPANY | Health Technology |
| Private Unternehmen | 4 |
|---|---|
NantKwest, Inc.
 NantKwest, Inc. BiotechnologyHealth Technology NantKwest, Inc. engages in the research and development of immunotherapies. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The company was founded by Gary N. Keller and Hans Georg Klingemannon October 7, 2002 and is headquartered in San Diego, CA. | Health Technology |
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Health Technology |
Aardvark Therapeutics, Inc.
Aardvark Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel small molecule therapeutics for obesity and metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA. | Health Technology |
Scilex, Inc.
Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | Health Technology |
